Division of Bacterial Diseases (DBD) News Bulletin - Fall 2014

November 7, 2014: Content on this page kept for historical reasons.

  • Ambrose J, Hampton LM, Fleming-Dutra KE, et al. Large outbreak of Legionnaires’ disease and Pontiac fever at a military base. Epidemiol Infect. 2014 Jan 30. [Epub ahead of print]
  • Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio. 2014;5:e01074.
  • Beaudoin A, Toso L, Richards K, et al. Invasive group A Streptococcus infections associated with liposuction surgery at outpatient facilities not subject to state or federal regulation. JAMA Intern Med. 2014;174:1136-42.
  • Bowden K, Williams M, Cassiday P, et al. Molecular epidemiology of pertussis epidemic — Washington state, 2012. J Clin Microbiol. 2014 Jul 16. [Epub ahead of print]
  • Domingues CM, Verani JR, Montenegro Renoiner El, et al. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med. 2014;2:464-71.
  • Harris AM, Beekmann SE, Polgreen PM, et al. Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers. Diagn Microbiol Infect Disexternal icon. 2014;79:454-7.
  • Li S, Rouphael N, Duraisingham S, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15:195-204.
  • Li Y, Yin Z, Shao Z, et al. Population-based surveillance for bacterial meningitis in China, September 2006—December 2009. Emerg Infect Dis. 2014;20:61-9.
  • Marini RP, Cassiday PK, Venezia J, et al. Corynebacterium ulcerans in ferrets. Emerg Infect Dis. 2014;159-61.
  • Park C, Nichols M, Schrag SJ. Two cases of invasive vancomycin-resistant group B Streptococcus infection. N Eng J Med. 2014;370:885-6.
  • Reynolds CA, Finkelstein JA, Ray GT, et al. Attributable healthcare utilization and cost of pneumonia due to drug-resistant Streptococcus pneumoniae. Antimicrob Resist Infect Control. 2014;3:16-23.
  • Sanchez GV, Hicks LA. Acute sinusitis and pharyngitis as inappropriate indications for antibiotic use. Antimicrob Agents Chemother. 2014;58:3572.
  • Srinivasan V, Metcalf BJ, Knipe KM, et al. vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus. MBio. 2014;5:e01386-14.
  • Suda KJ, Hicks LA, Roberts RM, et al. Trends and seasonal variation in outpatient antibiotic prescribing rates in the United States, 2006—2010. Antimicrob Agents Chemother. 2014;58:2763-6.
  • Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2014;63;822-825.
  • Verani JR, Spina NL, Lynfield R, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet gynecol. 2014;123:828-37.
  • Wortham JM, Zell ER, Pondo T, et al. Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. Clin Infect Dis. 2014;58:1250-7.
  • Zhou F, Shefer A, Wenger J, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014;133:577-85.

 Top of Page